TearLab Corporation Confirms Merger Discussions
07 mai 2020 08h00 HE
|
TearLab Corporation
ESCONDIDO, Calif., May 07, 2020 (GLOBE NEWSWIRE) -- In light of recent market rumors, TearLab Corporation (OTCQB: TEAR) (“TearLab”) today confirmed that TearLab is engaged in advanced discussions...
TearLab Resubmits 510(k) for U.S. FDA Clearance of the TearLab Discovery™ MMP-9 Test
22 avr. 2020 16h05 HE
|
TearLab Corporation
ESCONDIDO, Calif., April 22, 2020 (GLOBE NEWSWIRE) -- TearLab Corporation (OTCQB: TEAR) (“TearLab” or the “Company”) today announced that the U.S. Food and Drug Administration (FDA) has accepted the...
TearLab Corporation Reports Fourth Quarter and Full Year 2019 Financial Results
05 mars 2020 16h05 HE
|
TearLab Corporation
ESCONDIDO, Calif., March 05, 2020 (GLOBE NEWSWIRE) -- TearLab Corporation (OTCQB: TEAR) (“TearLab” or the “Company”) today reported its consolidated financial results for the fourth quarter and...
TearLab Corporation Reports Third Quarter 2019 Financial Results
07 nov. 2019 16h05 HE
|
TearLab Corporation
ESCONDIDO, Calif., Nov. 07, 2019 (GLOBE NEWSWIRE) -- TearLab Corporation (OTCQB: TEAR) (“TearLab” or the “Company”) today reported its consolidated financial results for the third quarter ended...
TearLab Corporation Reports Second Quarter and First Half 2019 Financial Results
08 août 2019 16h01 HE
|
TearLab Corporation
ESCONDIDO, Calif., Aug. 08, 2019 (GLOBE NEWSWIRE) -- TearLab Corporation (OTCQB: TEAR) (“TearLab” or the “Company”) today reported its consolidated financial results for the second quarter ended...
TearLab Corporation Reports First Quarter 2019 Financial Results
09 mai 2019 16h01 HE
|
TearLab Corporation
ESCONDIDO, Calif., May 09, 2019 (GLOBE NEWSWIRE) -- TearLab Corporation (OTCQB: TEAR) (“TearLab” or the “Company”) today reported its consolidated financial results for the first quarter ended March...
TearLab Corporation Reports Fourth Quarter and Full Year 2018 Financial Results
21 mars 2019 16h01 HE
|
TearLab Corporation
ESCONDIDO, Calif., March 21, 2019 (GLOBE NEWSWIRE) -- TearLab Corporation (OTCQB:TEAR) (“TearLab” or the “Company”) today reported its consolidated financial results for the fourth quarter and...
TearLab Corporation Reports Third Quarter 2018 Financial Results
07 nov. 2018 16h01 HE
|
TearLab Corporation
ESCONDIDO, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- TearLab Corporation (OTCQB: TEAR) (“TearLab” or the “Company”) today reported its consolidated financial results for the third quarter ended...
TearLab Update on 510(k) for U.S. FDA Clearance of Discovery™ MMP-9 Test
10 oct. 2018 18h00 HE
|
TearLab Corporation
SAN DIEGO, Oct. 10, 2018 (GLOBE NEWSWIRE) -- TearLab Corporation (OTCQB: TEAR) (“TearLab” or the “Company”), today announced that the U.S. Food and Drug Administration (FDA) has determined that the...
TearLab Corporation Reports Second Quarter and First Half 2018 Financial Results
09 août 2018 16h01 HE
|
TearLab Corporation
SAN DIEGO, Aug. 09, 2018 (GLOBE NEWSWIRE) -- TearLab Corporation (OTCQB: TEAR) (“TearLab” or the “Company”) today reported its consolidated financial results for the second quarter ended June 30,...